Beatrice Lusenti

Modena, 41126, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.

Journal: International journal of molecular sciences
Published: July 26, 2021

Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges.

Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges.

Journal: Cancers
Published: July 26, 2021

Pre-existing cytopenia heralding de novo acute myeloid leukemia: Uncommon presentation of NPM1-mutated AML in a single-center study.

Pre-existing cytopenia heralding de novo acute myeloid leukemia: Uncommon presentation of NPM1-mutated AML in a single-center study.

Journal: Leukemia research
Published: July 13, 2021

Chromosome 16 changes do not always come for good.

Chromosome 16 changes do not always come for good.

Journal: International journal of laboratory hematology
Published: March 25, 2021

Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients.

Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients.

Journal: Scientific reports
Published: February 22, 2021

Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies.

Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies.

Journal: International journal of molecular sciences
Published: January 15, 2021

Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation.

Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation.

Journal: Prostaglandins & other lipid mediators
Published: January 07, 2021

A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.

A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.

Journal: Platelets
Published: August 29, 2020

High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19.

High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19.

Journal: Annals of hematology
Published: August 15, 2020

The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19.

The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19.

Journal: Medical hypotheses
Published: June 10, 2020

Type 3 hypersensitivity in COVID-19 vasculitis.

Type 3 hypersensitivity in COVID-19 vasculitis.

Journal: Clinical immunology (Orlando, Fla.)
Published: May 23, 2020

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19.

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19.

Journal: Annals of hematology
Published: May 10, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026